Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line

NCT00116441 is registered in ClinicalTrials.gov with Cell Genesys as lead sponsor.

NCT NCT00116441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00116441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line
Lead sponsor
Cell Genesys
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2000
Completion date
October 31, 2004
Enrollment
22
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma